People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Mining & Resources, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MARATHON GOLD Corp | — | Mining & Resources | Series B | $27.2M | $92.4M | 2022 |
| PharmaCielo Ltd. | — | Pharmaceuticals | Series A | $22.8M | $195.6M | 2018 |
Douglas Bache at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Bache on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Gordon | 1 | 8 |
| Julian Kemp | 1 | 3 |
| George Faught | 1 | 3 |
| Kenneth Phillippe | 1 | 3 |
| James Gowans | 1 | 3 |
| Tim Williams | 1 | 3 |
| Joseph Spiteri | 1 | 2 |
| Janice Stairs | 1 | 2 |
| Anthony Wile | 1 | 2 |
| Simon Langelier | 1 | 2 |
| Phillip Walford | 1 | 2 |
| DELON HUMAN | 1 | 2 |
| Peter Macphail | 1 | 2 |
| John Knapp | 1 | 2 |
| David Yun | 1 | 2 |
| Matthew Manson | 1 | 2 |
| Robert Page Chilcott | 1 | 1 |
| James Daniel Frank | 1 | 1 |
| Joseph G. Spiteri | 1 | 1 |
| James David Kirke | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.